Antimicrobial activities of silver dressings: an in vitro comparison.
暂无分享,去创建一个
[1] Ben Wong,et al. Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection? , 2004, The Journal of antimicrobial chemotherapy.
[2] K. Harding,et al. Wound dressings in diabetic foot disease. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] P. Bowler,et al. Controlling wound bioburden with a novel silver‐containing Hydrofiber® dressing , 2004, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[4] V. Poon,et al. In vitro cytotoxity of silver: implication for clinical wound care. , 2004, Burns : journal of the International Society for Burn Injuries.
[5] R. Kimble,et al. An in vitro study of the anti-microbial efficacy of a 1% silver sulphadiazine and 0.2% chlorhexidine digluconate cream, 1% silver sulphadiazine cream and a silver coated dressing. , 2004, Burns : journal of the International Society for Burn Injuries.
[6] K. Andersen,et al. Clinical performance of a new silver dressing, Contreet Foam, for chronic exuding venous leg ulcers. , 2003, Journal of wound care.
[7] S. Silver,et al. Bacterial silver resistance: molecular biology and uses and misuses of silver compounds. , 2003, FEMS microbiology reviews.
[8] S. Thomas,et al. A comparison of the antimicrobial effects of four silver-containing dressings on three organisms. , 2003, Journal of wound care.
[9] A. Lansdown,et al. Silver. 2: Toxicity in mammals and how its products aid wound repair. , 2002, Journal of wound care.
[10] A. Lansdown,et al. Silver. I: Its antibacterial properties and mechanism of action. , 2002, Journal of wound care.
[11] S. Magnet,et al. Resistance-Nodulation-Cell Division-Type Efflux Pump Involved in Aminoglycoside Resistance in Acinetobacter baumannii Strain BM4454 , 2001, Antimicrobial Agents and Chemotherapy.
[12] R. White. An historical overview of the use of silver in wound management , 2001 .
[13] H J Klasen,et al. Historical review of the use of silver in the treatment of burns. I. Early uses. , 2000, Burns : journal of the International Society for Burn Injuries.
[14] R. Darouiche. Anti-infective efficacy of silver-coated medical prostheses. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] E Olsson,et al. Silver-based crystalline nanoparticles, microbially fabricated. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[16] R. Burrell,et al. Wound management in an era of increasing bacterial antibiotic resistance: a role for topical silver treatment. , 1998, American journal of infection control.
[17] A. Gupta,et al. Effects of Halides on Plasmid-Mediated Silver Resistance in Escherichia coli , 1998, Applied and Environmental Microbiology.
[18] J. Marshall,et al. Systemic argyria secondary to topical silver nitrate. , 1977, Archives of dermatology.
[19] D. Chinkes,et al. Therapeutic efficacy of three silver dressings in an infected animal model. , 2005, The Journal of burn care & rehabilitation.
[20] K. Foster,et al. Aquacel Ag in the management of partial-thickness burns: results of a clinical trial. , 2004, The Journal of burn care & rehabilitation.
[21] D. Ross,et al. The use of cerium nitrate-silver sulphadiazine as a topical burns dressing. , 1993, British journal of plastic surgery.